Involvement of integrin up-regulation in RANKL/RANK pathway of chondrosarcomas migration

Journal of Cellular Biochemistry

Volumn 111, Issue 1, 2010, Pages 138-147

  Hsu, Chin Jung ^a,b   Lin, Tsang Yu ^a   Kuo, Chien Chung ^b   Tsai, Chun Hao ^b   Lin, Mou Zen ^b   Hsu, Horng Chaung ^b   Fong, Yi Chin ^a,b   Tang, Chih Hsin ^a,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chondrosarcoma; ERK; Migration; RANK; RANKL

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BETA1 INTEGRIN; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; PYRROLIDINE DITHIOCARBAMATE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TOSYLPHENYLALANYL CHLOROMETHYL KETONE;

ARTICLE; CARTILAGE; CELL MIGRATION; CELL STIMULATION; CELL SURFACE; CHONDROSARCOMA; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANK SUM TEST; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CHONDROSARCOMA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTEGRINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM INVASIVENESS; NF-KAPPA B; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 77957165721     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22677     Document Type: Article

References (33)

1. Armstrong AP, Miller RE, Jones JC, Zhang J, Keller ET, Dougall WC. 2008. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. Prostate 68:92-104.
2. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
3. Chen G, Sircar K, Aprikian A, Potti A, Goltzman D, Rabbani SA. 2006. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 107:289-298. (Pubitemid 44036558)
4. Chen PS, Wang MY, Wu SN, Su JL, Hong CC, Chuang SE, Chen MW, Hua KT, Wu YL, Cha ST, Babu MS, Chen CN, Lee PH, Chang KJ, Kuo ML. 2007. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3- ERK1/2-dependent S100A4-upregulated pathway. J Cell Sci 120:2053-2065.
5. Darnay BG, Haridas V, Ni J, Moore PA, Aggarwal BB. 1998. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. J Biol Chem 273:20551-20555.
6. Darnay BG, Ni J, Moore PA, Aggarwal BB. 1999. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. J Biol Chem 274:7724-7731. (Pubitemid 129518159)
7. Fong YC, Yang WH, Hsu SF, Hsu HC, Tseng KF, Hsu CJ, Lee CY, Scully SP. 2007. 2-Methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells. J Orthop Res 25:1106-1114.
8. Fong YC, Li TM, Wu CM, Hsu SF, Kao ST, Chen RJ, Lin CC, Liu SC, Wu CL, Tang CH. 2008. BMP-2 increases migration of human chondrosarcoma cells via PI3K/Akt pathway. J Cell Physiol 217:846-855.
9. Fong YC, Hsu SF, Wu CL, Li TM, Kao ST, Tsai FJ, Chen WC, Liu SC, Wu CM, Tang CH. 2009. Transforming growth factor-beta1 increases cellmigrationand beta1 integrin up-regulation in human lung cancer cells. Lung Cancer 64:13-21.
10. Gupta GP, Massague J. 2006. Cancer metastasis: Building a framework. Cell 127:679-695.
11. Heyder C, Gloria-Maercker E, Hatzmann W, Niggemann B, Zanker KS, Dittmar T. 2005. Role of the beta1-integrin subunit in the adhesion, extravasation and migration of T24 human bladder carcinoma cells. Clin Exp Metastasis 22:99-106.
12. Heymann MF, Riet A, Le Goff B, Battaglia S, Paineau J, Heymann D. 2008. OPG, RANK and RANK ligand expression in thyroid lesions. Regul Pept 148:46-53.
13. Huang CY, Fong YC, Lee CY, Chen MY, Tsai HC, Hsu HC, Tang CH. 2009. CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways. Biochem Pharmacol 77:794-803.
14. Humphries MJ. 2000. Integrin structure. Biochem Soc Trans 28:311-339.
15. Kapur S, Baylink DJ, Lau KH. 2003. Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways. Bone 32:241-251. (Pubitemid 36349527)
16. Kearns AE, Khosla S, Kostenuik PJ. 2008. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29:155-192.
17. Knauf JA, Fagin JA. 2009. Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets. Curr Opin Cell Biol 21:296-303.
18. Lai TH, Fong YC, Fu WM, Yang RS, Tang CH. 2009. Stromal cell-derived factor-1 increase alphavbeta3 integrin expression and invasion in human chondrosarcoma cells. J Cell Physiol 218:334-342.
19. Lee SY, Reichlin A, Santana A, Sokol KA, Nussenzweig MC, Choi Y. 1997. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 7:703-713.
20. Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276:18934-18940. (Pubitemid 37411214)
21. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. 1999. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274:30353-30356.
22. Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. 2005. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res 65:4645-4652.
23. Stupack DG. 2007. The biology of integrins. Oncology (Williston Park) 21:6-12.
24. Takenaka K, Shibuya M, Takeda Y, Hibino S, Gemma A, Ono Y, Kudoh S. 2000. Altered expression and function of beta1 integrins in a highly metastatic human lung adenocarcinoma cell line. Int J Oncol 17:1187-1194.
25. Tang CH, Chuang JY, Fong YC, Maa MC, Way TD, Hung CH. 2008. Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells. Carcinogenesis 29:1483-1492.
26. Terek RM, Schwartz GK, Devaney K, Glantz L, Mak S, Healey JH, Albino AP. 1998. Chemotherapy and P-glycoprotein expression in chondrosarcoma. J Orthop Res 16:585-590.
27. Van Campenhout A, Golledge J. 2009. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 204:321-329.
28. Viatour P, Merville MP, Bours V, Chariot A. 2005. Phosphorylation of NF-kappaB and IkappaB proteins: Implications in cancer and inflammation. Trends Biochem Sci 30:43-52. (Pubitemid 40093740)
29. Virk MS, Petrigliano FA, Liu NQ, Chatziioannou AF, Stout D, Kang CO, Dougall WC, Lieberman JR. 2009. Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone. Bone 44:160-167.
30. White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, Muller WJ. 2004. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6:159-170.
31. Woodhouse EC, Chuaqui RF, Liotta LA. 1997. General mechanisms of metastasis. Cancer 80:1529-1537.
32. Yeh YY, Chiao CC, Kuo WY, Hsiao YC, Chen YJ, Wei YY, Lai TH, Fong YC, Tang CH. 2008. TGF-beta1 increases motility and alphavbeta3 integrin upregulation via PI3K, Akt and NF-kappaB-dependent pathway in human chondrosarcoma cells. Biochem Pharmacol 75:1292-1301.
33. Yuan J, Dutton CM, Scully SP. 2005. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J Orthop Res 23:1467-1474.